Halozyme Reports First Quarter 2021 Results

Go back to Halozyme Reports First Quarter 2021 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 112.45 +2.77 (2.53%)
Previous Close $109.68    52 Week High $18.39 
Open $109.72    52 Week Low $6.96 
Day High $112.66    P/E N/A 
Day Low $109.38    EPS $-0.58 
Volume 10,348,948